These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9377618)

  • 41. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
    Kato M; Asaka M; Kudo M; Sukegawa M; Katagiri M; Koshiyama T; Kagaya H; Nishikawa K; Hokari K; Takeda H; Sugiyama T
    Aliment Pharmacol Ther; 1996 Oct; 10(5):821-7. PubMed ID: 8899093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A trial of lansoprazole in refractory gastric ulcer.
    van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
    Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
    Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
    Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
    Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I; Fukuda Y; Okui M; Tamura K; Shimoyama T
    J Clin Gastroenterol; 1995; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
    Adachi K; Suetsugu H; Moriyama N; Kazumori H; Kawamura A; Fujishiro H; Sato H; Okuyama T; Ishihara S; Watanabe M; Kinoshita Y
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1211-6. PubMed ID: 11903737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    Gupta VK; Dhar A; Srinivasan S; Rattan A; Sharma MP
    Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
    Michel P; Lemaire M; Colin R; Bommelaer G; Rambaud JC; Dupas JL; Bigard MA; Verwaerd JC
    Aliment Pharmacol Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8186337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
    Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
    Lai KC; Lam SK; Chu KM; Hui WM; Kwok KF; Wong BC; Hu HC; Wong WM; Chan OO; Chan CK
    Aliment Pharmacol Ther; 2003 Oct; 18(8):829-36. PubMed ID: 14535877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.
    Arakawa T; Higuchi K; Fukuda T; Nakamura H; Kobayashi K
    J Clin Gastroenterol; 1991; 13 Suppl 1():S129-33. PubMed ID: 1682356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.